Bristol-Myers Squibb Co (BMY) Financials
Bristol-Myers Squibb Co (BMY) Historical Financial Statements and Key Metrics for 1987 - 2021
Full Bristol-Myers Squibb Co financials for 1987 - 2021 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Bristol-Myers Squibb Co Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2021-Mar-31 | 11,073 | 8,232 (74.3 %) | 1,828 (16.5 %) | 2,021 (18.3 %) | 4,496 | 0.89 |
| 2020-Dec-31 | 11,068 | 8,158 (73.7 %) | -839 (-7.6 %) | -10,027 (-90.6 %) | 1,851 | -4.45 |
| 2020-Sep-30 | 10,540 | 8,038 (76.3 %) | 1,342 (12.7 %) | 1,872 (17.8 %) | 3,997 | 0.82 |
| 2020-Jun-30 | 10,129 | 7,430 (73.4 %) | 891 (8.8 %) | -85 (-0.8 %) | 3,449 | -0.04 |
| 2020-Mar-31 | 10,781 | 7,119 (66.0 %) | 783 (7.3 %) | -775 (-7.2 %) | 3,260 | -0.34 |
| 2019-Dec-31 | 7,945 | 5,513 (69.4 %) | 557 (7.0 %) | -1,056 (-13.3 %) | 1,793 | -0.55 |
| 2019-Sep-30 | 6,007 | 4,197 (69.9 %) | 1,760 (29.3 %) | 1,353 (22.5 %) | 1,931 | 0.83 |
Full historical income statements for 1987 - 2021 is included in the
US Historical Financials dataset.
Bristol-Myers Squibb Co Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2021-Mar-31 | 112,435 | 74,762 | 46,282 | 37,605 | 13,137 |
| 2020-Dec-31 | 118,481 | 80,599 | 50,676 | 37,882 | 16,450 |
| 2020-Sep-30 | 125,536 | 75,306 | 44,949 | 50,230 | 21,281 |
| 2020-Jun-30 | 128,076 | 78,916 | 46,672 | 49,160 | 21,793 |
| 2020-Mar-31 | 129,285 | 79,308 | 46,706 | 49,977 | 18,322 |
| 2019-Dec-31 | 129,944 | 78,246 | 46,733 | 51,698 | 15,393 |
| 2019-Sep-30 | 57,433 | 39,679 | 24,959 | 17,754 | 32,542 |
Full historical balance sheet data for 1987 - 2021 is included in the
US Historical Financials dataset.
Bristol-Myers Squibb Co Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2021-Mar-31 | 3,824 | -143 | -7,295 | 3,651 |
| 2020-Dec-31 | 3,670 | -12,127 | 3,483 | 3,387 |
| 2020-Sep-30 | 2,219 | -165 | -2,587 | 2,066 |
| 2020-Jun-30 | 4,269 | 780 | -993 | 4,138 |
| 2020-Mar-31 | 3,894 | 653 | -1,054 | 3,708 |
| 2019-Dec-31 | 2,038 | -12,036 | -7,677 | 1,787 |
| 2019-Sep-30 | 2,556 | 491 | -941 | 2,366 |
Full historical cash flow data for 1987 - 2021 is included in the
US Historical Financials dataset.
Bristol-Myers Squibb Co Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2021-Mar-31 | 141,159 | 176,459 | 12.75 | 17.46 | 3.75 |
| 2020-Dec-31 | 139,692 | 175,822 | 12.62 | -3.48 | 3.69 |
| 2020-Sep-30 | 136,075 | 161,589 | 12.91 | 18.17 | 2.71 |
| 2020-Jun-30 | 133,064 | 159,802 | 13.14 | -391.37 | 2.71 |
| 2020-Mar-31 | 125,861 | 156,750 | 11.67 | -40.60 | 2.52 |
| 2019-Dec-31 | 123,116 | 157,503 | 15.50 | -29.15 | 2.38 |
| 2019-Sep-30 | 82,759 | 77,229 | 13.78 | 15.29 | 4.66 |
Full historical valuation and operating metrics for 1987 - 2021 are included in the
US Historical Financials dataset.